Document is current
Any future updates will be listed below
-
Authors
Ortiz, Justin R. https://orcid.org/0000-0002-3138-5965
Kurup, Drishya https://orcid.org/0000-0002-3959-7700
Kaufman, Adam C. https://orcid.org/0000-0003-1367-7566
Ben Hamed, Sabrine
LaRocco, Allison M.
Lyke, Kirsten E. https://orcid.org/0000-0002-4966-0830
Litts, Sarah M.
Datta, Shrimati
Liang, Yuanyuan
McGilvray, Megan F.
Losignor, Jeannie A.
Oshinsky, Jennifer J. https://orcid.org/0000-0002-6919-6780
Palmer, Kari V.
Johnson-Mayo, Ifayet PL
Scher, Gabrielle
Balakumar, Uthra https://orcid.org/0009-0000-7959-3037
Chandwani, Anisha
Rapaka, Rekha R.
Deming, Meagan E. https://orcid.org/0000-0003-2574-0542
Chua, Joel V.
Wirblich, Christoph
Chen, Wilbur H. https://orcid.org/0000-0001-7741-5536
Neuzil, Kathleen M.
Pasetti, Marcela F. https://orcid.org/0000-0003-0894-4009
Schnell, Matthias J.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201700082C)
- License Information
-
More Information
Article History
Received: 7 October 2025
Accepted: 28 April 2026
First Online: 9 June 2026
Competing interests
: W.H.C. serves as the US FDA IND sponsor representative for the investigational vaccine. J.R.O. is a member of the Moderna Therapeutics New Vaccines Advisory Board, a consultant for ENA Respiratory, and reports research funding from ENA Respiratory and Pfizer provided to his institution. R.R.R. is currently employed by Moderna Therapeutics and may own Moderna shares. M.J.S. has a pending patent application for 3D-6-acyl PHAD-SE. All other authors declare no competing interests.
